Hsp90 Activity Modulation by Plant Secondary Metabolites
暂无分享,去创建一个
[1] D. Tang,et al. Comparative investigation of in vitro biotransformation of 14 components in Ginkgo biloba extract in normal, diabetes and diabetic nephropathy rat intestinal bacteria matrix. , 2014, Journal of pharmaceutical and biomedical analysis.
[2] P. Ismail,et al. Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer. , 2014, European journal of pharmacology.
[3] C. Ramos,et al. The effect of celastrol, a triterpene with antitumorigenic activity, on conformational and functional aspects of the human 90kDa heat shock protein Hsp90α, a chaperone implicated in the stabilization of the tumor phenotype. , 2014, Biochimica et biophysica acta.
[4] E. Bae,et al. Inhibition of adipocyte inflammation and macrophage chemotaxis by butein. , 2014, European journal of pharmacology.
[5] R. Bhat,et al. Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors. , 2014, Journal of medicinal chemistry.
[6] S. Paul,et al. Identifying a C-terminal ATP binding sites-based novel Hsp90-Inhibitor in silico: a plausible therapeutic approach in Alzheimer's disease. , 2014, Medical hypotheses.
[7] L. Luo,et al. Luteolin is effective in the non‐small cell lung cancer model with L858R/T790M EGF receptor mutation and erlotinib resistance , 2014, British journal of pharmacology.
[8] Y. Seo,et al. Synthesis of Butein Analogues and their Anti-proliferative Activity Against Gefitinib-resistant Non-small Cell Lung Cancer (NSCLC) through Hsp90 Inhibition , 2014 .
[9] G. Chiosis,et al. Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions , 2014, Expert opinion on investigational drugs.
[10] Aykut Ozgur and Yusuf Tutar. Heat Shock Protein 90 Inhibitors in Oncology , 2014 .
[11] Jianxing He,et al. Celastrol Induces Apoptosis in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells via Caspases-Dependent Pathways and Hsp90 Client Protein Degradation , 2014, Molecules.
[12] R. Cotugno,et al. Bioactive limonoids from the leaves of Azaridachta indica (Neem). , 2014, Journal of natural products.
[13] Jun Ye,et al. Celastrol Induces Apoptosis of Gastric Cancer Cells by miR-21 Inhibiting PI3K/Akt-NF-κB Signaling Pathway , 2014, Pharmacology.
[14] C. Chi,et al. Andrographolide downregulates the v-Src and Bcr-Abl oncoproteins and induces Hsp90 cleavage in the ROS-dependent suppression of cancer malignancy. , 2014, Biochemical pharmacology.
[15] L. Luo,et al. Luteolin exhibits anti-inflammatory effects by blocking the activity of heat shock protein 90 in macrophages. , 2014, Biochemical and biophysical research communications.
[16] Y. Seo,et al. Synthesis of Flavokawain B and Its anti‐Proliferative Activity Against Gefitinib‐Resistant Non‐Small Cell Lung Cancer (NSCLC). , 2013 .
[17] Y. Seo. Butein Disrupts Hsp90's Molecular Chaperoning Function and Exhibits Anti-proliferative Effects Against Drug-resistant Cancer Cells , 2013 .
[18] A. Leone,et al. Identification of the Plant Compound Geraniin as a Novel Hsp90 Inhibitor , 2013, PloS one.
[19] J. Patki,et al. HSP90: Chaperone-me-not , 2013, Pathology & Oncology Research.
[20] Jia Li,et al. Geraniin induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro and in vivo. , 2013, Canadian journal of physiology and pharmacology.
[21] S. Guan,et al. ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3β in the signal network , 2013, Cell Death and Disease.
[22] Jie Liu,et al. Celastrol protects human neuroblastoma SH-SY5Y cells from rotenone-induced injury through induction of autophagy , 2013, Neurochemistry International.
[23] J. Park,et al. Geraniin down regulates gamma radiation-induced apoptosis by suppressing DNA damage. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[24] Chih-Yang Huang,et al. Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERα Inhibition , 2013, Evidence-based complementary and alternative medicine : eCAM.
[25] X. Zi,et al. Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis , 2013, Molecular Cancer.
[26] Agostino Casapullo,et al. Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor. , 2013, Chemical communications.
[27] C. Garrido,et al. Targeting heat shock proteins in cancer. , 2013, Cancer letters.
[28] Y. Ikeda,et al. Non-Specific Protein Modifications by a Phytochemical Induce Heat Shock Response for Self-Defense , 2013, PloS one.
[29] H. Matsunaga,et al. Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors. , 2013, Analytical biochemistry.
[30] G. Bifulco,et al. A chemical-biological study reveals C9-type iridoids as novel heat shock protein 90 (Hsp90) inhibitors. , 2013, Journal of medicinal chemistry.
[31] G. Su,et al. Proteomic analysis of the effect of triterpenes from Patrinia heterophylla on leukemia K562 cells. , 2012, Journal of ethnopharmacology.
[32] Shufeng Zhou,et al. Mechanism of reversal of high glucose-induced endothelial nitric oxide synthase uncoupling by tanshinone IIA in human endothelial cell line EA.hy926. , 2012, European journal of pharmacology.
[33] Biplab Bhattacharjee,et al. Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[34] L. Luo,et al. Luteolin Induces Carcinoma Cell Apoptosis through Binding Hsp90 to Suppress Constitutive Activation of STAT3 , 2012, PloS one.
[35] A. Vassallo,et al. Biflavonoids from Daphne linearifolia Hart. , 2012 .
[36] G. Bifulco,et al. Natural Iminosugar (+)-Lentiginosine Inhibits ATPase and Chaperone Activity of Hsp90 , 2012, PloS one.
[37] N. Grammatikakis,et al. Cell Surface Cdc37 Participates in Extracellular HSP90 Mediated Cancer Cell Invasion , 2012, PloS one.
[38] E. Wattenberg,et al. Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog. , 2012, Biochemical and biophysical research communications.
[39] F. Villarreal,et al. (-)-Epicatechin-induced calcium independent eNOS activation: roles of HSP90 and AKT , 2012, Molecular and Cellular Biochemistry.
[40] A. Gomes,et al. Black tea polyphenols induce human leukemic cell cycle arrest by inhibiting Akt signaling , 2012, The FEBS journal.
[41] X. Zi,et al. Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[42] Haihua Feng,et al. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. , 2012, Journal of agricultural and food chemistry.
[43] Hsueh-Wei Chang,et al. Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo. , 2012, The Journal of nutritional biochemistry.
[44] T. Zhu,et al. β-Elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells , 2012, Journal of Neuro-Oncology.
[45] Lianfeng Zhang,et al. Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo. , 2012, Bioorganic & medicinal chemistry letters.
[46] J. Stanslas,et al. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer , 2012, Clinical and experimental pharmacology & physiology.
[47] G. Bifulco,et al. Structural characterization of tetranortriterpenes from Pseudrocedrela kotschyi and Trichilia emetica and study of their activity towards the chaperone Hsp90. , 2012, Phytochemistry.
[48] K. Subbaramaiah,et al. Carnosol, a Constituent of Zyflamend, Inhibits Aryl Hydrocarbon Receptor–Mediated Activation of CYP1A1 and CYP1B1 Transcription and Mutagenesis , 2012, Cancer Prevention Research.
[49] M. Lilly,et al. Kava Components Down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice , 2012, PloS one.
[50] M. Motilva,et al. Metabolic pathways of the colonic metabolism of flavonoids (flavonols, flavones and flavanones) and phenolic acids , 2012 .
[51] Paul Workman,et al. Hsp90 Molecular Chaperone Inhibitors: Are We There Yet? , 2012, Clinical Cancer Research.
[52] Ming Zhao,et al. Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90 , 2011, Molecular Cancer.
[53] Zhe-Sheng Chen,et al. Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu. , 2011, Molecular pharmaceutics.
[54] C. Hunt,et al. Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins. , 2011, Bioorganic & medicinal chemistry.
[55] G. Sethi,et al. Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways , 2011, Apoptosis.
[56] Weimin Zhao. Introduction to Natural Products Chemistry , 2011 .
[57] I. Warner,et al. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro. , 2011, Chemico-biological interactions.
[58] P. Oliveira,et al. Berberine as a promising safe anti-cancer agent - is there a role for mitochondria? , 2011, Current drug targets.
[59] B. Blagg,et al. Gambogic acid, a natural product inhibitor of Hsp90. , 2011, Journal of natural products.
[60] Xiaodan Yu,et al. Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells , 2011, BMC Cancer.
[61] A. Kinghorn,et al. Absolute configuration of (-)-gambogic acid, an antitumor agent. , 2011, Journal of natural products.
[62] S. Ni,et al. Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. , 2011, Cancer letters.
[63] M. Rogosnitzky,et al. Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions , 2011 .
[64] Si-Yang Song,et al. Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells. , 2010, Biochemical and biophysical research communications.
[65] M. Konopleva,et al. Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma , 2010, British Journal of Cancer.
[66] Taher Abbasi,et al. Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo , 2010, Clinical Cancer Research.
[67] Shu-mei Lin,et al. Butein downregulates phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in cancerous and non-cancerous breast cells. , 2010, European journal of pharmacology.
[68] G. Sethi,et al. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells. , 2010, Biochemical pharmacology.
[69] Erin E. Carlson,et al. Natural products as chemical probes. , 2010, ACS chemical biology.
[70] P. Chueh,et al. Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: Involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells. , 2010, Free radical biology & medicine.
[71] Sang‐Gun Ahn,et al. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo , 2010, BMC Cancer.
[72] Chunxin Yang,et al. Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way , 2010, Cell Stress and Chaperones.
[73] Bi-Fong Lin,et al. Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian) , 2010, Chinese medicine.
[74] Lin Qiu,et al. Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation. , 2010, Cancer letters.
[75] G. Uzan,et al. HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way , 2010, Molecular Cancer.
[76] A. Salminen,et al. Celastrol: Molecular targets of Thunder God Vine. , 2010, Biochemical and biophysical research communications.
[77] S. Shukla,et al. Apigenin: A Promising Molecule for Cancer Prevention , 2010, Pharmaceutical Research.
[78] Q. Dou,et al. Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells. , 2010, International journal of molecular medicine.
[79] J. Holzbeierlein,et al. Hsp90: A Drug Target? , 2010, Current oncology reports.
[80] M. Ramirez-Alvarado,et al. Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23* , 2009, The Journal of Biological Chemistry.
[81] U. Testa,et al. Triterpenoids as new promising anticancer drugs. , 2009, Anti-cancer drugs.
[82] S. Tsao,et al. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. , 2009, Journal of ethnopharmacology.
[83] Tao Zhang,et al. Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction* , 2009, The Journal of Biological Chemistry.
[84] A. Aura,et al. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. , 2009, Molecular nutrition & food research.
[85] H. Schwalbe,et al. Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. , 2009, Angewandte Chemie.
[86] Tao Zhang,et al. (-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2. , 2009, Molecular pharmaceutics.
[87] W. Wong,et al. A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-kb Pathway , 2022 .
[88] H. Canatan,et al. In vitro and in vivo anti-inflammatory effects of andrographolide. , 2009, International immunopharmacology.
[89] J. M. Kim,et al. 5,7‐dihydroxy‐3,4,6‐trimethoxyflavone inhibits the inflammatory effects induced by Bacteroides fragilis enterotoxin via dissociating the complex of heat shock protein 90 and IκBα and IκB kinase‐γ in intestinal epithelial cell culture , 2009, Clinical and experimental immunology.
[90] Tao Zhang,et al. New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. , 2009, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[91] S. Kwon,et al. Anti-cancer effect of Betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2 D SDS PAGE coupled with nano-HPLC tandem Mass Spectrometry. , 2009, Planta medica.
[92] T. Gasiewicz,et al. (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. , 2009, Biochemistry.
[93] J. Reynolds,et al. The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down‐regulating the expression of heat shock protein 90 , 2008, The Prostate.
[94] K. Subbaramaiah,et al. Heat Shock Protein 90 Inhibitors Suppress Aryl Hydrocarbon Receptor–Mediated Activation of CYP1A1 and CYP1B1 Transcription and DNA Adduct Formation , 2008, Cancer Prevention Research.
[95] B. Blagg,et al. Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships. , 2008, Journal of medicinal chemistry.
[96] I. Merfort,et al. Anti-Oxidant, Anti-Inflammatory and Anti-Allergic Activities of Luteolin , 2008, Planta medica.
[97] Y. Kwon,et al. Quercetin‐induced ubiquitination and down‐regulation of Her‐2/neu , 2008, Journal of cellular biochemistry.
[98] I. Merfort,et al. Anti-carcinogenic Effects of the Flavonoid Luteolin , 2008, Molecules.
[99] Winston Yu-Chen Chen,et al. Molecular Simulation of HER2/neu Degradation by Inhibiting HSP90 , 2008 .
[100] B. Blagg,et al. Synthesis and evaluation of derrubone and select analogues. , 2008, The Journal of organic chemistry.
[101] Tao Zhang,et al. A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells , 2008, Molecular Cancer Therapeutics.
[102] J. Gestwicki,et al. Derrubone, an inhibitor of the Hsp90 protein folding machinery. , 2007, Journal of natural products.
[103] S. Fu,et al. Suppression of v-Src Transformation by Andrographolide via Degradation of the v-Src Protein and Attenuation of the Erk Signaling Pathway* , 2007, Journal of Biological Chemistry.
[104] G. Williams,et al. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[105] T. Ceremuga,et al. Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. , 2007, AANA journal.
[106] L. Marnett,et al. Identification of the protein targets of the reactive metabolite of teucrin A in vivo in the rat. , 2007, Chemical research in toxicology.
[107] B. Aggarwal,et al. Butein, a Tetrahydroxychalcone, Inhibits Nuclear Factor (NF)-κB and NF-κB-regulated Gene Expression through Direct Inhibition of IκBα Kinase β on Cysteine 179 Residue* , 2007, Journal of Biological Chemistry.
[108] Di Chen,et al. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. , 2007, Cancer research.
[109] E. A. Rogozin,et al. Direct Inhibition of Insulin-Like Growth Factor-I Receptor Kinase Activity by (−)−Epigallocatechin-3-Gallate Regulates Cell Transformation , 2007, Cancer Epidemiology Biomarkers & Prevention.
[110] A. Martineau,et al. Quercetin, Siamois 1 and siamois 2 induce apoptosis in human breast cancer MDA-MB-435 cells xenograft in vivo , 2007, Cancer biology & therapy.
[111] Xianglin Shi,et al. Chrysin inhibits expression of hypoxia-inducible factor-1α through reducing hypoxia-inducible factor-1α stability and inhibiting its protein synthesis , 2007, Molecular Cancer Therapeutics.
[112] T. Golub,et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.
[113] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[114] R. Xu,et al. [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine]. , 2006, Zhonghua yi xue za zhi.
[115] Neal Rosen,et al. Hsp90: a novel target for cancer therapy. , 2006, Current topics in medicinal chemistry.
[116] Di Chen,et al. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. , 2006, Cancer research.
[117] S. Lindquist,et al. HSP90 and the chaperoning of cancer , 2005, Nature Reviews Cancer.
[118] R. Keast,et al. Phytochemistry: Ibuprofen-like activity in extra-virgin olive oil , 2005, Nature.
[119] P. Murphy,et al. Human gut microbial degradation of flavonoids: structure-function relationships. , 2005, Journal of agricultural and food chemistry.
[120] T. Gasiewicz,et al. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. , 2005, Biochemistry.
[121] D. Sohn,et al. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells. , 2004, Biochemical and biophysical research communications.
[122] S. Imaoka,et al. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF‐1α protein , 2004, FEBS letters.
[123] Z. Darżynkiewicz,et al. Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. , 2004, Biochemical and biophysical research communications.
[124] Hong Zhang,et al. Targeting multiple signal transduction pathways through inhibition of Hsp90 , 2004, Journal of Molecular Medicine.
[125] K. Itoh,et al. Role of Intestinal Flora on the Metabolism, Absorption, and Biological Activity of Dietary Flavonoids , 2003 .
[126] J. Kanner,et al. Antioxidant and prooxidant effects of phenolics on pancreatic β-cells in vitro , 2002 .
[127] Y. Surh,et al. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces apoptosis in human promyelocytic leukemia cells. , 2001, Mutation research.
[128] L. Neckers,et al. The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxyl Terminus of the Chaperone* , 2000, The Journal of Biological Chemistry.
[129] Steiner Gg. The correlation between cancer incidence and kava consumption. , 2000 .
[130] S. Shibata,et al. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. , 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[131] Hui-Kang Wang. The therapeutic potential of flavonoids , 2000, Expert opinion on investigational drugs.
[132] L. Pearl,et al. Structure and in vivo function of Hsp90. , 2000, Current opinion in structural biology.
[133] J. Buchner,et al. The Hsp90 complex--a super-chaperone machine as a novel drug target. , 1998, Biochemical pharmacology.
[134] A. Nakai,et al. Quercetin suppresses heat shock response by down regulation of HSF1. , 1995, Biochemical and biophysical research communications.
[135] I. Kapétanidis,et al. Flavonoids from Iochroma gesnerioides. , 1994, Pharmaceutica Acta Helvetiae.
[136] J. Medina,et al. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora Coerulea , 1994, Pharmacology Biochemistry and Behavior.
[137] E. Middleton,et al. Effects of flavonoids on immune and inflammatory cell functions. , 1992, Biochemical pharmacology.
[138] A. Elbein,et al. Lentiginosine, a dihydroxyindolizidine alkaloid that inhibits amyloglucosidase. , 1990, Biochemistry.
[139] T. Hatano,et al. Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects. , 1988, Chemical & pharmaceutical bulletin.
[140] B. Henderson,et al. Cancer incidence in the islands of the Pacific. , 1985, National Cancer Institute monograph.
[141] T. Mabry,et al. Antibacterial activity studies of flavonoids from Salvia palaestina. , 1983, Journal of natural products.
[142] E. Paulus,et al. Condensed tannins. 10. Isolation of (--)-butin and butein from wattle heartwoods. , 1961, The Biochemical journal.
[143] R. Jahan,et al. A review on berbamine a - a potential anticancer drug. , 2014 .
[144] Zheng,et al. Blockade of Her 2 / neu binding to Hsp 90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her 2 / neu , 2012 .
[145] B. Blagg,et al. The synthesis and evaluation of flavone and isoflavone chimeras of novobiocin and derrubone. , 2010, Bioorganic & medicinal chemistry.
[146] Yun‐Sil Lee,et al. Celastrol binds to ERK and inhibits FcεRI signaling to exert an anti-allergic effect , 2009 .
[147] B. Aggarwal,et al. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue. , 2007, The Journal of biological chemistry.
[148] Ou Qiao-ming. Studies on chemical constituents from Patrinia heterophylla Bunge. and their cytotoxicity in vitro , 2007 .
[149] S. Shukla,et al. Apigenin and cancer chemoprevention: progress, potential and promise (review). , 2007, International journal of oncology.
[150] L. Neckers. Chaperoning oncogenes: Hsp90 as a target of geldanamycin. , 2006, Handbook of experimental pharmacology.
[151] S. Kimura,et al. Inhibition of leukemic cell growth by a novel anti‐cancer drug (GUT‐70) from calophyllum brasiliense that acts by induction of apoptosis , 2005, International journal of cancer.
[152] Woo-Kyu Park,et al. Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. , 2004, Pharmacological research.
[153] G. Steiner. The correlation between cancer incidence and kava consumption. , 2000, Hawaii medical journal.
[154] P. Cohen,et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.
[155] M. Gábor. Anti-inflammatory and anti-allergic properties of flavonoids. , 1986, Progress in clinical and biological research.
[156] R. E. Wheeler,et al. Natural occurrence of 3-aryl-4-hydroxycoumarins. Part I. Phytochemical examination of Derris robusta(roxb.) benth. , 1969 .
[157] D. Hathway. The Condensed Tannins , 1962 .